Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial

BACKGROUND: Recently, the use of taxane-based regimens before anthracycline-based regimens has been shown to achieve high pathological complete response (pCR) rates in patients with breast cancer. Nanoparticle albumin-bound paclitaxel (nab-PTX) has been reported as highly effective and less toxic co...

Descripción completa

Detalles Bibliográficos
Autores principales: Futamura, Manabu, Nagao, Yasuko, Ishihara, Kazuhiro, Takeuchi, Makoto, Nakada, Takumi, Kawaguchi, Yoshihiro, Asano, Masayoshi, Kumazawa, Iwao, Shiroko, Takashi, Morimitsu, Kasumi, Mori, Ryutaro, Nawa, Masahito, Shimokawa, Toshio, Yoshida, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487880/
https://www.ncbi.nlm.nih.gov/pubmed/28050738
http://dx.doi.org/10.1007/s12282-016-0748-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487880/
https://www.ncbi.nlm.nih.gov/pubmed/28050738
http://dx.doi.org/10.1007/s12282-016-0748-6

Ejemplares similares